SCHEIBLER LUKAS
Insider CIK 1651281 · M?????? EVP of Translational Medicine · APLS See Remarks
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2023-12-01 | 2023-12-05 | 10,000 | — | $0 | 39,391 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2023-12-01 | 2023-12-05 | 10,000 | $13.85 | $138.5K | 78,299 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-12-01 | 2023-12-05 | 10,000 | $60.00 | $600.0K | 68,299 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2023-09-06 | 2023-09-07 | 1,756 | $43.01 | $75.5K | 68,299 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-02-21 | 2023-02-22 | 14,023 | — | $0 | 14,023 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-02-21 | 2023-02-22 | 9,886 | — | $0 | 70,358 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-02-21 | 2023-02-22 | 715 | $58.50 | $41.8K | 69,643 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-02-10 | 2023-02-14 | 678 | $51.21 | $34.7K | 60,472 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-27 | 2023-01-30 | 542 | $52.77 | $28.6K | 61,150 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2023-01-20 | 2023-01-24 | 2,015 | $52.05 | $104.9K | 61,692 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2023-01-12 | 2023-01-17 | 35,472 | $52.66 | $1.87M | 35,472 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2023-01-12 | 2023-01-17 | 22,580 | — | $0 | 63,707 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-05-27 | 2022-05-31 | 10,000 | $43.00 | $430.0K | 40,358 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other deriv | 2022-04-21 | 2022-05-31 | 11,250 | — | $0 | 0 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | J Other | 2022-04-21 | 2022-05-31 | 1,875 | — | $0 | 50,358 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-04-05 | 2022-04-06 | 609 | — | $0 | 49,391 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-04-05 | 2022-04-06 | 609 | $60.09 | $36.6K | 52,233 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-04-05 | 2022-04-06 | 609 | $13.85 | $8.4K | 52,842 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-04-04 | 2022-04-05 | 3,504 | — | $0 | 50,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-04-04 | 2022-04-05 | 3,504 | $13.85 | $48.5K | 55,737 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-04-04 | 2022-04-05 | 818 | $55.84 | $45.7K | 54,919 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-04-04 | 2022-04-05 | 1,437 | $56.86 | $81.7K | 53,482 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-04-04 | 2022-04-05 | 1,249 | $57.81 | $72.2K | 52,233 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-04-01 | 2022-04-04 | 11,496 | — | $0 | 53,504 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-04-01 | 2022-04-04 | 11,496 | $13.85 | $159.2K | 63,729 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-04-01 | 2022-04-04 | 11,496 | $55.05 | $632.9K | 52,233 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-02-14 | 2022-02-15 | 720 | — | $0 | 133,777 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-02-14 | 2022-02-15 | 720 | $26.73 | $19.2K | 52,233 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-02-11 | 2022-02-14 | 1,666 | $46.80 | $78.0K | 51,513 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-02-10 | 2022-02-14 | 10,000 | — | $0 | 65,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-02-10 | 2022-02-14 | 678 | $47.12 | $31.9K | 53,179 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-02-10 | 2022-02-14 | 10,000 | $13.85 | $138.5K | 63,179 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-02-10 | 2022-02-14 | 10,000 | $50.00 | $500.0K | 53,179 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-02-08 | 2022-02-10 | 10,000 | — | $0 | 75,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-02-08 | 2022-02-10 | 10,000 | $45.00 | $450.0K | 53,857 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-02-08 | 2022-02-10 | 10,000 | $13.85 | $138.5K | 63,857 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2022-01-31 | 2022-02-01 | 1,233 | $38.47 | $47.4K | 53,857 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2022-01-28 | 2022-02-01 | 642 | $38.59 | $24.8K | 55,090 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2022-01-21 | 2022-01-24 | 3,021 | — | $0 | 134,497 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2022-01-21 | 2022-01-25 | 36,951 | — | $0 | 36,951 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2022-01-21 | 2022-01-24 | 3,021 | $26.73 | $80.8K | 29,681 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2022-01-21 | 2022-01-25 | 26,051 | — | $0 | 55,732 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | S Sale | 2021-06-10 | 2021-06-11 | 3,417 | $60.00 | $205.0K | 26,651 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | F Tax w/h | 2021-02-10 | 2021-02-11 | 680 | $47.72 | $32.4K | 29,290 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 11,250 | — | $0 | 11,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2021-01-28 | 2021-02-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 7,500 | — | $0 | 28,095 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2021-01-28 | 2021-02-01 | 1,875 | — | $0 | 29,970 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise deriv | 2020-12-08 | 2020-12-09 | 7,482 | — | $0 | 137,518 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | M Exercise | 2020-12-08 | 2020-12-09 | 7,482 | $26.73 | $200.0K | 20,595 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2020-02-10 | 2020-02-12 | 56,250 | — | $0 | 56,250 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award | 2020-02-10 | 2020-02-12 | 9,375 | — | $0 | 12,310 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2019-02-08 | 2019-02-12 | 85,000 | — | $0 | 85,000 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | P Buy | 2018-05-24 | 2018-05-29 | 2,935 | $20.37 | $59.8K | 2,935 | SEC↗ |
| APLS Apellis Pharmaceuticals, I | A Award deriv | 2018-04-13 | 2018-04-17 | 145,000 | — | $0 | 145,000 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-07-17 | 2017-07-18 | 2,663 | — | $0 | 66,587 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-07-17 | 2017-07-18 | 2,663 | — | $0 | 12,358 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-07-17 | 2017-07-18 | 1,250 | $6.50 | $8.1K | 11,108 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-06-20 | 2017-06-20 | 1,300 | $6.95 | $9.0K | 9,695 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-06-17 | 2017-06-20 | 2,664 | — | $0 | 69,250 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-06-17 | 2017-06-20 | 2,664 | — | $0 | 10,995 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-05-17 | 2017-05-18 | 2,663 | — | $0 | 71,914 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-05-17 | 2017-05-18 | 1,275 | $6.15 | $7.8K | 8,331 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-05-17 | 2017-05-18 | 2,663 | — | $0 | 9,606 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-04-17 | 2017-04-17 | 2,664 | — | $0 | 74,577 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-04-17 | 2017-04-17 | 2,664 | — | $0 | 8,263 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-04-17 | 2017-04-17 | 1,320 | $6.48 | $8.6K | 6,943 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-03-20 | 2017-03-20 | 1,250 | $7.10 | $8.9K | 5,599 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-03-17 | 2017-03-20 | 2,663 | — | $0 | 77,241 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-03-17 | 2017-03-20 | 2,663 | — | $0 | 6,849 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-02-17 | 2017-02-21 | 2,664 | — | $0 | 79,904 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-02-17 | 2017-02-21 | 1,450 | $8.10 | $11.7K | 4,186 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-02-17 | 2017-02-21 | 2,664 | — | $0 | 5,636 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2017-01-18 | 2017-01-20 | 1,475 | $8.70 | $12.8K | 2,972 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2017-01-17 | 2017-01-20 | 2,663 | — | $0 | 82,568 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2017-01-17 | 2017-01-20 | 2,663 | — | $0 | 4,447 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise deriv | 2016-12-22 | 2016-12-27 | 2,664 | — | $0 | 85,231 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | M Exercise | 2016-12-22 | 2016-12-27 | 2,664 | — | $0 | 2,664 | SEC↗ |
| M?????? KUBOTA PHARMACEUTICAL HOLD | S Sale | 2016-12-22 | 2016-12-27 | 880 | $8.18 | $7.2K | 1,784 | SEC↗ |
| M?????? ACUCELA INC. | S Sale | 2016-11-21 | 2016-11-21 | 2,663 | $9.35 | $24.9K | 0 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise deriv | 2016-11-17 | 2016-11-21 | 2,663 | — | $0 | 87,895 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise | 2016-11-17 | 2016-11-21 | 2,663 | — | $0 | 2,663 | SEC↗ |
| M?????? ACUCELA INC. | S Sale | 2016-11-14 | 2016-11-15 | 1,774 | $9.44 | $16.7K | 0 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise deriv | 2016-10-17 | 2016-10-18 | 2,664 | — | $0 | 90,558 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise | 2016-10-17 | 2016-10-18 | 2,664 | — | $0 | 2,664 | SEC↗ |
| M?????? ACUCELA INC. | F Tax w/h | 2016-10-17 | 2016-10-18 | 890 | $11.48 | $10.2K | 1,774 | SEC↗ |
| M?????? ACUCELA INC. | S Sale | 2016-09-20 | 2016-09-20 | 2,663 | $9.53 | $25.4K | 0 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise deriv | 2016-09-17 | 2016-09-20 | 2,663 | — | $0 | 93,222 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise | 2016-09-17 | 2016-09-20 | 2,663 | — | $0 | 2,663 | SEC↗ |
| M?????? ACUCELA INC. | S Sale | 2016-08-18 | 2016-08-18 | 31,962 | $10.81 | $345.5K | 0 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise deriv | 2016-08-17 | 2016-08-18 | 31,962 | — | $0 | 95,885 | SEC↗ |
| M?????? ACUCELA INC. | M Exercise | 2016-08-17 | 2016-08-18 | 31,962 | — | $0 | 31,962 | SEC↗ |
| M?????? ACUCELA INC. | A Award deriv | 2016-07-12 | 2016-07-14 | 87,555 | — | $0 | 87,555 | SEC↗ |
| M?????? ACUCELA INC. | A Award deriv | 2016-07-12 | 2016-07-14 | 32,445 | — | $0 | 32,445 | SEC↗ |
| M?????? ACUCELA INC. | A Award deriv | 2015-08-17 | 2015-08-19 | 127,847 | — | $0 | 127,847 | SEC↗ |